Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Maravai Life Sciences

Explore full profile

Life-science reagents and testing products for vaccines, therapies, diagnostics and research

San Diego, United StatesFounded 2014Biotech & Life Sciences
Valuation $1.07B Market cap · Aug/2026
Revenue $210M Latest reported FY

At a glance

Founded
2014
Headquarters
San Diego, United States
Listing
IPO 2020
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Maravai Life Sciences.

See all news

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • GTCR
Employees mapped 85 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 14 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States98.8%
🇨🇦 Canada1.2%
2 countries shown
Web traffic by country
4.3K monthly visits
across markets
🇺🇸 United States67.4%
🇮🇳 India25.6%
🇵🇭 Philippines4.7%
🇬🇧 United Kingdom4.7%
Top 4 markets shown

Patents

Estimated portfolio value
$8M

3 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Maravai Life Sciences was the backer or acquirer, 2016–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Maravai Life Sciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Maravai Life Sciences deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Maravai Life Sciences's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Maravai Life Sciences on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Maravai Life Sciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.